AN ACT to amend Tennessee Code Annotated, Title 8; Title 56 and Title 71, relative to health insurance.
Impact
The legislation is set to enhance the availability of essential medical equipment for diabetes management, which is an important step in supporting the health and welfare of insulin-dependent individuals. By requiring insurance coverage for CGMs, the bill not only improves individual access to necessary healthcare devices, but it helps to address public health issues related to diabetes. Coverage mandates may lead to increased utilization of CGMs, potentially resulting in better health outcomes for patients.
Summary
Senate Bill 755 (SB0755) proposes amendments to the Tennessee Code Annotated concerning health insurance coverage specifically for continuous glucose monitors (CGMs) for individuals with diabetes who are insulin-dependent. The bill mandates that health insurance policies provide coverage for CGMs starting from July 1, 2023, ensuring that such devices are accessible for those who require them as part of their medical management. This measure is significant as it addresses the needs of a vulnerable population and aims to improve diabetes care and management in the state.
Contention
While the bill is generally seen as a positive move towards better healthcare access, potential points of contention may arise regarding insurance providers' administrative processes related to claims for CGM coverage. Insurers may implement managed care strategies, which could complicate access for some patients. Furthermore, certain exclusions stated in the bill, such as those for specific types of insurance policies (like Medicare supplements and long-term care), may limit the effectiveness of the bill for some individuals, raising concerns about equitable healthcare access across all insurance types.